<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(28)</volume><submitter>Nesheim N</submitter><pubmed_abstract>Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is associated with urinary tract symptoms and hormonal imbalances amongst others. The heterogeneous clinical presentation, unexplored molecular background and lack of prostate biopsies complicate therapy. Here, using liquid biopsies, we performed a comprehensive translational study on men diagnosed with CP/CPPS type III (&lt;i>n&lt;/i>&lt;b>&lt;i>=&lt;/i>&lt;/b> 50; median age 39.8, range 23-65) and age-matched controls (&lt;i>n&lt;/i>&lt;b>&lt;i>=&lt;/i>&lt;/b> 61; median age 36.8, range 20-69), considering biochemical parameters of blood and ejaculates, and epigenetic regulation of the estrogen receptor genes (&lt;i>ESR1&lt;/i> and &lt;i>ESR2&lt;/i>) in leukocytes isolated from blood (systemic regulation) and in somatic cells isolated from ejaculates (local regulation). We fou</pubmed_abstract><journal>Oncotarget</journal><pagination>19623-19639</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5929413</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Elevated seminal plasma estradiol and epigenetic inactivation of &lt;i>ESR1&lt;/i> and &lt;i>ESR2&lt;/i> is associated with CP/CPPS.</pubmed_title><pmcid>PMC5929413</pmcid><pubmed_authors>Pilatz A</pubmed_authors><pubmed_authors>Weidner W</pubmed_authors><pubmed_authors>Schuppe HC</pubmed_authors><pubmed_authors>Dansranjavin T</pubmed_authors><pubmed_authors>Berg E</pubmed_authors><pubmed_authors>Schagdarsurengin U</pubmed_authors><pubmed_authors>Ellem S</pubmed_authors><pubmed_authors>Schambeck R</pubmed_authors><pubmed_authors>Risbridger G</pubmed_authors><pubmed_authors>Nesheim N</pubmed_authors><pubmed_authors>Wagenlehner F</pubmed_authors><pubmed_authors>Hagenkotter C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Elevated seminal plasma estradiol and epigenetic inactivation of &lt;i>ESR1&lt;/i> and &lt;i>ESR2&lt;/i> is associated with CP/CPPS.</name><description>Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is associated with urinary tract symptoms and hormonal imbalances amongst others. The heterogeneous clinical presentation, unexplored molecular background and lack of prostate biopsies complicate therapy. Here, using liquid biopsies, we performed a comprehensive translational study on men diagnosed with CP/CPPS type III (&lt;i>n&lt;/i>&lt;b>&lt;i>=&lt;/i>&lt;/b> 50; median age 39.8, range 23-65) and age-matched controls (&lt;i>n&lt;/i>&lt;b>&lt;i>=&lt;/i>&lt;/b> 61; median age 36.8, range 20-69), considering biochemical parameters of blood and ejaculates, and epigenetic regulation of the estrogen receptor genes (&lt;i>ESR1&lt;/i> and &lt;i>ESR2&lt;/i>) in leukocytes isolated from blood (systemic regulation) and in somatic cells isolated from ejaculates (local regulation). We fou</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Apr</publication><modification>2026-07-15T21:17:20.207Z</modification><creation>2025-06-01T12:39:30.016Z</creation></dates><accession>S-EPMC5929413</accession><cross_references><pubmed>29731970</pubmed><doi>10.18632/oncotarget.24714</doi></cross_references></HashMap>